Mezlocillin sodium monohydrate - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for mezlocillin sodium monohydrate and what is the scope of patent protection?
Mezlocillin sodium monohydrate
is the generic ingredient in one branded drug marketed by Bayer Pharms and is included in four NDAs. Additional information is available in the individual branded drug profile pages.Summary for mezlocillin sodium monohydrate
| US Patents: | 0 |
| Tradenames: | 1 |
| Applicants: | 1 |
| NDAs: | 4 |
| Raw Ingredient (Bulk) Api Vendors: | 2 |
| DailyMed Link: | mezlocillin sodium monohydrate at DailyMed |
Medical Subject Heading (MeSH) Categories for mezlocillin sodium monohydrate
Anatomical Therapeutic Chemical (ATC) Classes for mezlocillin sodium monohydrate
US Patents and Regulatory Information for mezlocillin sodium monohydrate
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bayer Pharms | MEZLIN | mezlocillin sodium monohydrate | INJECTABLE;INJECTION | 050549-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Bayer Pharms | MEZLIN | mezlocillin sodium monohydrate | INJECTABLE;INJECTION | 062372-001 | May 13, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Bayer Pharms | MEZLIN | mezlocillin sodium monohydrate | INJECTABLE;INJECTION | 062372-004 | Mar 2, 1988 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
